Allscripts (MDRX) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Dow futures hit three-month low as yields surge, Micron earnings offer support
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise 2% as China suspends fuel exports
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Leerink Swann Downgrades Allscripts (MDRX) to Market Perform
February 27, 2015 6:56 AM ESTLeerink Swann downgraded Allscripts (NASDAQ: MDRX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $12.75 yesterday.
... More